Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

American Lung Association Announces New Research Funding Available Including New Award to Cure Lung Cancer in Women

The American Lung Association, currently funding more than $6.49 million in groundbreaking research, continues its investment in lung health research, expecting to offer at least $6.5 million dollars in new grants in fiscal year 2017, including a new research award with a focus on lung cancer in women.

NYT opinion page features a quartet of commentaries on DCIS research

Last week, a major study on the risks of ductal carcinoma in situ (DCIS) was published in JAMA Oncology. The results spurred the New York Times editorial section to run not one, but four different commentaries on the results.

Kubtec Patent Promotes Strong Prognosis for the Future of Breast Conserving Surgery

Kubtec®, the leader in innovation for digital specimen radiography systems, announces the U.S. Patent & Trademark Office has issued Patent No. 14/503,130 for the technology incorporated into the  Mozart® System with TomoSpec® Technology. 

Thumbnail

Studying stage 0: Questions about DCIS

A major study this week in JAMA Oncology, which looked at mortality rates following a diagnosis of ductal carcinoma in situ (DCIS), provided some important insights and challenged preconceived notions. It also spurred even more questions.

Rethinking breast cancer risks: Study expands understanding of DCIS mortality

In the discussions and debates around the optimal breast cancer screening strategies, overdiagnosis and overtreatment concerns loom large. Now, a study published in JAMA Oncology might be cause to reevaluate the detection and treatment of ductal carcinoma in situ (DCIS), or stage 0 cancer.

Isotope Technologies Garching GmbH Announces In-licensing of DOTA-Zoledronate for Bone Targeted Radionuclide Theranostics of Osseous Metastases

The ITM Group announced today that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next generation theranostic agent for Bone Targeted Radionuclide Therapy and Diagnostics in patients suffering from bone metastases. 

Perseon Launches INSPIRE 2017, a Dramatic Effort to Increase Adoption of Microwave Ablation to Fight Cancer

Perseon Corporation (Nasdaq:PRSN), today announced the launch of INSPIRE 2017, a new campaign which is dedicated to the growth and direction of the company over the next three years, particularly in the area of lung cancer, a disease where MicroThermX is better suited to treatment than other energy ablation products due to the system's 915 MHz frequency and synchronous wave alignment technology.

Thumbnail

Structural MRI offers insights into autism

Italian researchers are touting the possibility that structural MRI might be able to predict the development of autism spectrum disorders and help guide treatment options.

Displaying 4081 - 4088 of 23546

Around the web

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care.